Elevated ATG4B and ATG4D expression was significantly associated with reduced distant metastasis in NPC patients (P = 0.019) and within the EBV-positive subgroup (P = 0.014). The gene discussed is ATG4D; the disease is nasopharyngeal carcinoma.